Exhibit 99.1 Press Release dated March 23, 2023 Contact:Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-889-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results DUBLIN, Ireland (March 23, 2023)…. Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended Dec ...